Silence Therapeutics (SLN) Cash from Financing Activities (2024 - 2026)
Silence Therapeutics (SLN) posted Cash from Financing Activities of $1000.0 for Q2 2025, down 92.86% sequentially from $14000.0 in Q1 2025, and down 99.92% YoY from $1.2 million in Q2 2024.
Silence Therapeutics (SLN) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Silence Therapeutics has reported Cash from Financing Activities for 2 years, with the latest figure at $1000.0 in Q2 2025.
- Quarterly Cash from Financing Activities fell 99.92% year-over-year to $1000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $1000.0 (down 99.99% YoY) and the FY2025 annual result came in at $15000.0, down 99.99% from the prior year.
- Cash from Financing Activities slipped to $1000.0 in Q2 2025 per SLN's latest filing, from $14000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $133.0 million in Q1 2024 and troughed at -$98000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.42 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -6.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -207,909.22 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -273.15 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 36.24 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 27.18 Mn |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Jun 30, 2026 | 2,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | -98,000.00 |
| Dec 31, 2024 | -98,000.00 |
| Sep 30, 2024 | 7.97 Mn |
| Sep 30, 2024 | 7.97 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 133.02 Mn |
| Mar 31, 2024 | 133.02 Mn |